利尔化学(002258) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥1,481,933,864.23, representing a 51.10% increase compared to ¥980,776,297.84 in the same period last year[10] - Net profit attributable to shareholders for Q1 2021 was ¥220,781,407.74, a significant increase of 164.79% from ¥83,380,824.15 in the previous year[10] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥213,349,455.73, up 174.38% from ¥77,758,121.79 year-on-year[10] - Basic earnings per share for Q1 2021 were ¥0.4210, reflecting a 164.78% increase from ¥0.1590 in the previous year[10] - Diluted earnings per share for Q1 2021 were ¥0.4031, a rise of 153.52% compared to ¥0.1590 in the same period last year[10] - The net profit attributable to shareholders for the period is 400 million CNY, representing a 56.61% increase compared to the previous year's 255.41 million CNY[39] - Basic earnings per share increased by 56.52% to 0.7624 CNY from 0.4871 CNY in the same period last year[39] Cash Flow and Liquidity - The net cash flow from operating activities for Q1 2021 was ¥75,788,109.36, an increase of 184.45% compared to ¥26,643,401.43 in the same period last year[10] - The net cash flow from operating activities was ¥75,788,109.36, compared to ¥26,643,401.43 in the previous period, reflecting improved cash generation[65] - The net cash flow from operating activities was 87,780,279.86, down from 172,026,749.36 in the previous period, indicating a decrease of approximately 49.1%[71] - Cash inflow from financing activities amounted to 433,790,177.75, significantly higher than 133,000,000.00 in the previous period, representing an increase of approximately 226.7%[71] - The ending balance of cash and cash equivalents was 453,174,663.75, up from 365,331,572.52 in the previous period[71] Assets and Liabilities - Total assets at the end of Q1 2021 were ¥8,649,503,157.03, a 2.20% increase from ¥8,463,205,858.12 at the end of the previous year[10] - Net assets attributable to shareholders at the end of Q1 2021 were ¥4,094,441,647.89, up 3.07% from ¥3,972,556,171.06 at the end of the previous year[10] - Total liabilities rose to ¥2,545,556,875.54, compared to ¥2,415,508,800.13, indicating an increase of approximately 5.4%[56] - Current assets totaled ¥2,840,379,809.17, a decrease from ¥2,931,979,075.92, reflecting a decline of approximately 3.1%[53] - Non-current assets increased to ¥3,246,697,587.92 from ¥2,928,097,744.63, marking a growth of about 10.9%[53] Operational Highlights - Operating revenue increased by 51.10% to CNY 148,193.39 million compared to CNY 98,077.63 million in the previous period, driven by sales growth[18] - Operating costs rose by 46.22% to CNY 106,120.07 million, reflecting increased costs associated with higher revenue[18] - Cash received from sales of goods and services increased by 37.73% to CNY 99,021.51 million, attributed to higher sales collections[18] - The company completed the construction of a production line for 10,000 tons of glyphosate raw materials and a production line for 1,000 tons of acetochlor raw materials, both reaching the intended usable state[37] Investment and Expenditures - Cash paid for capital expenditures increased by 89.80% to CNY 21,360.25 million, indicating a rise in capital spending[18] - The company paid 92,589,099.58 for the acquisition of fixed assets, a significant rise from 21,318,427.44 in the previous period[71] Risk Management and Derivatives - The company reported a derivative investment loss of 77.79 million, with a fair value change of the derivatives confirmed during the reporting period[34] - The company has established internal control measures for foreign exchange derivative transactions to mitigate risks associated with market fluctuations[34] - The company aims to enhance its ability to respond to foreign exchange risks and prevent adverse impacts from significant exchange rate fluctuations[34] - The company has a risk management framework in place to address potential risks related to derivative investments, including market, liquidity, and credit risks[34] Future Outlook - The company anticipates a significant change in cumulative net profit for the year, with a warning of potential losses compared to the previous year[37] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[56]